Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Comorbid Depression and Cognitive Impairment in Older Adults With Neurocognitive Disorders Using Deep Transcranial Magnetic Stimulation (dTMS)

NCT03665831 is registered in ClinicalTrials.gov with Rotman Research Institute at Baycrest as lead sponsor.

NCT NCT03665831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03665831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Comorbid Depression and Cognitive Impairment in Older Adults With Neurocognitive Disorders Using Deep Transcranial Magnetic Stimulation (dTMS)
Lead sponsor
Rotman Research Institute at Baycrest
Phase
Not applicable
Overall status
Recruiting
Start date
October 23, 2018
Completion date
September 15, 2026
Enrollment
28 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, major depressive disorder, mild cognitive impairment